In Vitro Reconstitution and Kinetic Characterization of the Essential Condensation Enzymes Involved in Prodiginine and Tambjamine Biosynthesis

2019 ◽  
Author(s):  
Katherine J. Picott ◽  
Julie A. Deichert ◽  
Ella M. deKemp ◽  
Avena Ross

We have reconstituted<i> </i>the <i>in vitro</i> activity of the purified condensation enzymes PigC and TamQ, from prodiginine and tambjamine pathways respectively. Upon analysis and comparison of their kinetic profiles, a ping-pong reaction sequence with substrate inhibition was identified for each condensation enzyme.

2019 ◽  
Author(s):  
Katherine J. Picott ◽  
Julie A. Deichert ◽  
Ella M. deKemp ◽  
Avena Ross

We have reconstituted<i> </i>the <i>in vitro</i> activity of the purified condensation enzymes PigC and TamQ, from prodiginine and tambjamine pathways respectively. Upon analysis and comparison of their kinetic profiles, a ping-pong reaction sequence with substrate inhibition was identified for each condensation enzyme.


2011 ◽  
Vol 133 (32) ◽  
pp. 12801-12809 ◽  
Author(s):  
Fabien Durand ◽  
Benoît Limoges ◽  
Nicolas Mano ◽  
François Mavré ◽  
Rebeca Miranda-Castro ◽  
...  

2015 ◽  
Vol 466 (2) ◽  
pp. 243-251 ◽  
Author(s):  
Xiabin Chen ◽  
Xiaoqin Huang ◽  
Liyi Geng ◽  
Liu Xue ◽  
Shurong Hou ◽  
...  

Mouse (mBChE) and human butyrylcholinesterase (hBChE)-based cocaine hydrolases (mCocH and hCocH) have remarkably different catalytic efficiencies against cocaine, but with little differences in catalytic efficiencies against acetylcholine (ACh) and butyrylthiocholine (BTC). The amino-acid mutations have remarkably converted substrate activation of the enzymes into substrate inhibition.


Author(s):  
Carlos Moreno-Yruela ◽  
Andreas Stahl Madsen ◽  
Christian A. Olsen

Abstract Histone deacetylase (HDAC) inhibitors are employed for the treatment of lymphoma and are under development against multiple other types of cancer and neurodegenerative diseases. Here, we describe a robust and uncomplicated in vitro assay for HDAC inhibitor kinetic profiling. Enzyme and fluorogenic peptide substrate are incubated together with a small amount of protease “assay developer”, which enables continuous recording of substrate conversion under steady-state conditions. Assay progression curves upon addition of an inhibitors at varying concentrations permit determination of kinetic constants and overall inhibitor potency. This assay helped provide new insight into the kinetic properties of known HDAC inhibitors as well as the kinetic characterization of both inhibitors and substrates of sirtuin enzymes, which are class III HDACs involved in metabolic control and oncogene regulation.


Biochemistry ◽  
2000 ◽  
Vol 39 (36) ◽  
pp. 11050-11056 ◽  
Author(s):  
Dirk Linke ◽  
Joachim Frank ◽  
Josef F. Holzwarth ◽  
Jürgen Soll ◽  
Christoph Boettcher ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document